4-(2-METHYLOXAZOL-4-YL)BENZONITRILE, 95.0%, 250mg

2-Amino-3-(5-fluoro-2-nitrophenyl)propanoic acid hydrochloride, 98%, 1g

(6-Bromo-2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanol, 95%, 100mg

2-(1-Methoxy-1-methyl-ethyl)-benzofuran-5-carboxylic acid, 95.0%, 1g

n-Undecane, min. 95%, for synthesis, 500 ml, glass packaging

6-Nitro-1,2,3,4-tetrahydroquinoxaline, 95.0%, 25g

(R)-1-phenylethanamine (2S,3S,4R)-4-(benzo[d][1,3]dioxol-5-yl)-1-(tert-butoxycarbonyl)-2-(4-methoxyphenyl)pyrrolidine-3-carboxylate, 98%, 100mg

(2-(Piperidin-1-yl)pyridin-3-yl)methanol, 95.0%, 1g

L-(-)-Fucose, 95.0%, 25g

4-Methoxy-2-(trifluoromethyl)aniline, 98.0%, 1g

Naphthalene-2,6-diyl diacetate, 95.0%, 5g

4,4'-Diisopropylbiphenyl25g

Malonic acid, min. 99%, for synthesis, 100 g, glass packaging